IndigeQuit: a culturally tailored quit-smoking smartphone program for American Indian and Alaska Native adults
Official title: Digital Smoking Cessation Intervention for Nationally-Recruited American Indians and Alaska Natives: A Full-Scale Randomized Controlled Trial (IndigeQuit)
Run by Fred Hutchinson Cancer Center · NCT06145763 · Data updated 2026-11-12
This project tests whether the IndigeQuit smartphone app helps American Indian and Alaska Native adults quit smoking more effectively than the NCI QuitGuide app.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 776 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | July 3, 2025 |
| Main results expected | November 30, 2027 |
| Study ends | November 30, 2028 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT06145763 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are AI/AN adults (18+) who smoke daily, want to quit within 30 days, can read English, own an Android or iPhone, are willing to be randomized, and can complete follow-up assessments.
✕Probably not a fit
People without a personal smartphone, who cannot read English, who are already using other smoking cessation treatments, or who are not ready to quit in the next month are unlikely to benefit from enrolling.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Eligible participants who self-identify as American Indian or Alaska Native, are 18 or older, and smoke daily are randomized to use either the IndigeQuit app or the NCI QuitGuide app and asked to use it for at least 45 days. The IndigeQuit arm includes a personalized quit plan, eight progressive content levels, on-demand coping tools, and daily smoking tracking; the comparator arm uses the NCI QuitGuide app. Participants provide biospecimens and complete surveys, and outcomes are assessed at 3, 6, and 12 months. The intervention is delivered remotely via participants' own smartphones and excludes those currently using other cessation behavioral or pharmacologic treatments.
Why it matters
Potential benefit: If successful, IndigeQuit could provide a low-cost, culturally tailored, widely accessible way for more American Indian and Alaska Native smokers to quit.
How similar studies have gone: Mobile smoking-cessation apps have produced modest improvements in quit rates in general populations, but culturally tailored digital interventions for AI/AN people are novel and less well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as American Indian or Alaska Native, either alone or in combination with other races * Age 18 and older * Has smoked daily for the past year * Interest in quitting smoking within the next 30 days * Willing to be randomly assigned to either app * Have daily access to their own Android or iPhone * Able to download a smartphone app * Be willing and able to read English * Not currently or within past 30 days using other smoking cessation behavioral interventions or smoking cessation pharmacotherapies * Have never participated in our prior research * Have no other household or family member participating * Being willing to complete the 3, 6, and 12-month follow-up assessments * Providing email, phone number(s), and mailing address * Living off United States (US) AI/AN tribal reservations or living on five Northern Plains tribal reservations from whom we would obtain approvals to recruit Exclusion Criteria: * Currently (i.e., within past 30 days) using other smoking cessation behavioral interventions * Has participated in our prior research trials * Has used the National Cancer Institute's (NCI's) QuitGuide app * Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization * Not providing email, phone number(s), and mailing address
Where it's running
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Jonathan B. Bricker — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Brie Sullivan
- Email: bsulliva@fredhutch.org
- Phone: 206-667-5238
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nicotine's Effects on Eye Movements in E-Cigarette Users
This study tests how nicotine from e-cigarettes affects eye movements and related behaviors in adults who regularly use nicotine-containing e-cigarettes.
-
Tobacco and cannabis co-use: how young adults start, escalate, and maintain dual use
This project sees how 18–30-year-olds who use cannabis weekly start, escalate, and keep using either daily cigarettes or daily nicotine vapes.
-
Carcinogen and toxicant exposure among young adults who co-use e-cigarettes and cannabis
This project will measure nicotine, cannabis, and toxicant levels in blood and urine and compare use behaviors in 18–25-year-olds who primarily use e-cigarettes, cannabis, or both.
-
How menthol and cooling agents change the appeal of oral nicotine pouches
This test checks whether menthol, a synthetic cooling agent (WS-3), or both make oral nicotine pouches more appealing and better at relieving cravings for adult cigarette smokers.
-
Testing how well smokers can identify cigarette flavors
This study tests how well daily smokers can recognize different flavors in menthol cigarettes to understand how it affects their smoking habits.
-
Oral nicotine pouches versus patches and lozenges to reduce cigarette use in rural Appalachia
This compares oral nicotine pouches with nicotine patches and lozenges to see if they help adults in rural Appalachia who smoke cut down or quit cigarettes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.